Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

359
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
359
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

461
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
461
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

262
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
262
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

277
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
277
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

246
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous transanal evisceration of the small bowel through perforation of the sigmoid colon: a case report and new surgical approach.

International journal of surgery case reports·2026
Same author

Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical Trial.

JAMA network open·2025
Same author

Open versus laparoscopic right colectomy: does the initial approach impact on management and outcomein anastomotic leakage? A multicenter cohort study.

Updates in surgery·2025
Same author

Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial.

MedComm·2025
Same author

[Practical guideline for short bowel syndrome].

Zeitschrift fur Gastroenterologie·2025
Same author

Disease-specific B cell clones are shared between patients with Crohn's disease.

Nature communications·2025

Related Experiment Video

Updated: Oct 23, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

418

Bridging intestinal failure with Teduglutide - A case report.

Lukas Schlager1, Anton Stift1, Johanna Gartner2

  • 1Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Austria.

International Journal of Surgery Case Reports
|August 21, 2021
PubMed
Summary

Teduglutide, a GLP-2 analogue, can be used as a novel bridging therapy for intestinal reconstruction in patients with short bowel syndrome and intestinal failure (SBS-IF). This approach optimizes nutrition preoperatively, avoiding parenteral support and facilitating successful surgery.

Keywords:
Bridging intestinal failureGLP-2Intestinal failureShort bowel syndromeTeduglutide

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.4K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.1K

Related Experiment Videos

Last Updated: Oct 23, 2025

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

418
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.4K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.1K

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Pharmacology

Background:

  • Intestinal failure (IF) impairs nutrient absorption, often resulting from short bowel syndrome (SBS).
  • Teduglutide, a glucagon-like peptide 2 (GLP-2) analogue, is used to reduce parenteral support in SBS-IF by promoting intestinal mucosa growth.
  • Teduglutide is typically a long-term treatment after SBS-IF diagnosis.

Purpose of the Study:

  • To present a novel strategy using teduglutide as a bridging therapy for intestinal reconstruction.
  • To evaluate the feasibility of achieving enteral autonomy preoperatively with teduglutide.
  • To assess the outcomes of intestinal reconstruction following teduglutide bridging therapy.

Main Methods:

  • A case report detailing the use of teduglutide as a preoperative bridging therapy.
  • Monitoring patient's nutritional status and achieving enteral autonomy before surgery.
  • Performing intestinal reconstruction and assessing postoperative outcomes.

Main Results:

  • The patient achieved preoperative enteral autonomy using teduglutide.
  • Successful intestinal reconstruction was performed.
  • The patient maintained enteral autonomy postoperatively.

Conclusions:

  • Controlled use of teduglutide can optimize nutritional status preoperatively without parenteral support.
  • Teduglutide bridging therapy can facilitate earlier and simpler intestinal reconstruction.
  • This represents the first reported case of teduglutide used as bridging therapy to intestinal reconstruction.